Cambridge, MA, United States of America

Rohith Nagari

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Rohith Nagari

Introduction

Rohith Nagari is an accomplished inventor based in Cambridge, MA, who has made significant contributions to the field of cancer research. With a total of three patents to his name, he has focused on developing innovative methods for the diagnosis and treatment of various cancers. His work is particularly notable for its potential to improve therapeutic options for patients.

Latest Patents

Nagari's latest patents include groundbreaking research on cancers associated with the loss of chromosome 16Q and low expression of metallothionein proteins. This patent outlines compositions and methods for diagnosing and treating cancers that exhibit specific genetic markers, such as certain uterine, ovarian, gastroesophageal, and lung cancers. The patent highlights the use of three known drugs—disulfiram, elesclomol, and thiram—as effective agents for targeting cancer cells characterized by these genetic alterations.

Another significant patent focuses on aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics. This research addresses cancers that show elevated expression of FOXA1 and its gene targets, including specific forms of breast, liver, and prostate cancers. The patent details the use of adenosine receptor antagonists, such as CGS-15943, MRS-1220, and SCH-58261, as potential treatments for these cancers.

Career Highlights

Throughout his career, Rohith Nagari has worked with prestigious organizations, including the Broad Institute and Dana-Farber Cancer Institute. His experience in these leading research institutions has allowed him to collaborate with some of the brightest minds in the field, further enhancing his contributions to cancer research.

Collaborations

Nagari has collaborated with notable colleagues, including Steven Corsello and Ryan Spangler. These partnerships have played a crucial role in advancing his research and expanding the impact of his innovations in cancer treatment.

Conclusion

Rohith Nagari's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents reflect a commitment to improving patient outcomes through targeted therapies. As he continues to develop new methods and compositions, his contributions are likely to have a lasting impact on the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…